NIH institute director says breakthroughs require basic science

March 8, 2010 at 2:11 am 3 comments

On March 5, Jeremy Berg, director of the National Institute of General Medical Sciences at the National Institutes of Health, briefed congressional staffers on the importance of basic science for medical breakthroughs.  In remarks that highlighted recent Nobel Prize-winning research, Berg detailed how basic science discoveries are leading to advances against diseases such as cancer and heart disease.

“You can’t translate things you don’t understand,” Berg said, paraphrasing former NIH Director Elias Zerhouni.  While translating discoveries into cures is essential, medical breakthroughs require an understanding of the basic science behind disease, Berg said.

In his presentation, Berg highlighted the work of ASBMB member Carol Greider and her colleagues Elizabeth Blackburn and Jack W. Szostak who received the 2009 Nobel Prize in Medicine. Their research about how telomeres and telomerase protect chromosomes has led to importance advances against cancer.

While their use is often questioned, model organisms – such as yeast, fruit flies and mice –are important for medically relevant discoveries, Berg said.  Telomerase and telomeres originally were studied in protozoans known as Tetrahymena, and more recent research with beetles has made discoveries relevant for anti-cancer drugs, Berg said.

But, he said, the discovery of telomerase is just one of many success stories for researchers funded by NIGMS.  Since its founding in 1962, NIGMS has funded the prize-winning research of 73 Nobel laureates, Berg said.

Discoveries can take years to be fully appreciated, but some newer basic science research already is beginning to inform medical treatment.  Berg detailed new research in pharmacogenomics that uses a patient’s genome to more accurately predict the appropriate dose of life-saving medications.

The congressional briefing was organized by the Ad Hoc Group for Medical Research and co-sponsored by ASBMB, the Federation of American Societies for Experimental Biology and 13 other medical research focused organizations.

Find out more about NIGMS on its Web site.

Entry filed under: NIH. Tags: .

Former FASEB staffer to join NIH leadership MIT dean to be NSF director

3 Comments Add your own

  • 1. Bettie Sue Masters  |  March 20, 2010 at 12:15 am

    What a friend we have in Jeremy Berg!

    One of the questions I asked repeatedly, when on the Advisory Committee to the Director of NIH (2000-2004), was who will win the Nobel Prizes in the next generation of scientists in the light of the dramatic trend toward big science and the funding of multidisciplinary science at the expense of individual investigator- initiated research? How does one identify who actually had the ideas and performed the work?

    –Bettie Sue Masters

    Reply
  • [...] NIH institute director says breakthroughs require basic science … [...]

    Reply
  • 3. Nicole, PLR  |  April 12, 2011 at 3:10 pm

    “You can’t translate things you don’t understand,”

    This doesn’t just go for Science but for everything else in this world!

    Reply

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Connecting to %s

Trackback this post  |  Subscribe to the comments via RSS Feed


Categories

ASBMB Tweets

 

March 2010
M T W T F S S
« Feb   Apr »
1234567
891011121314
15161718192021
22232425262728
293031  

RSS ASBMB News

  • Rutgers team discovers novel approach to stimulate immune cells
    Research builds towards potential treatment for immune diseases and cancer May 14 2012 — Researchers at Rutgers University have uncovered a new way to stimulate activity of immune cell opiate receptors leading to efficient tumor cell clearance. ARTICLE CAPSULE Opiate Antagonist Prevents µ- and δ-Opiate Receptor Dimerization to Facilitate Ability of Agonist t […]
  • JBC Podcast: single-stranded DNA scanning enzymes
    A discussion with Myron Goodman and David Rueda May 4 2012 — In this podcast we hear an interview with Myron Goodman from the University of Southern California and David Rueda from Wayne State University who talk about the collaboration which led to their JBC Paper of the Week Singled-stranded DNA Scanning and Deamination by APOBEC3G at Single Molecular Reso […]
  • Researchers gain better understanding of mechanism behind tau spreading in the brain
    And the progression of Alzheimer's disease May 2 2012 — Researchers at Mount Sinai School of Medicine have gained insight into the mechanism by which a pathological brain protein called tau contributes to the progression of Alzheimer's disease (AD) and other neurodegenerative disorders This finding published in the most recent issue of The Journal […]
  • Online Now: May 2012 issue of ASBMB Today
    May 2 2012 – In this month's issue of ASBMB Today science writer Raj Mukhopadhyay profiles scientist-turned-artist Robert Schimke who once served as president of ASBMB and as an editorial board member for the Journal of Biological Chemistry Know a student who is graduating? ASBMB Today contributor Connor Bamford lists his top-10 picks for graduation gif […]
  • TssM is an energizer of a bacterial type VI secretion system
    Important for organism’s its ability to transfer DNA into plants May 1 2012 — Erh-Min Lai’s laboratory at Taiwan’s Institute of Plant and Microbial Biology has reported the energetic role of TssM in the type VI secretion system (T6SS) of Agrobacterium tumefaciens a plant pathogen and important organism for biotechnology because of its ability to transfer DNA […]

Follow

Get every new post delivered to your Inbox.